Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125874655 | 12587465 | 5 | F | 20160705 | 20160805 | 20160725 | 20160817 | EXP | JP-PFIZER INC-2016352104 | PFIZER | 85.00 | YR | M | Y | 0.00000 | 20160817 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125874655 | 12587465 | 1 | PS | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous drip | 4.5 G, 1X/DAY | 14 | G | 50684 | 4.5 | G | QD | |||||
| 125874655 | 12587465 | 2 | SS | TULOBUTEROL | TULOBUTEROL | 1 | Occlusive dressing technique | UNK | 0 | TRANSDERMAL PATCH | |||||||||
| 125874655 | 12587465 | 3 | SS | FERROUS CITRATE SODIUM | SODIUM FERROUS CITRATE | 1 | Oral | UNK | 0 | ||||||||||
| 125874655 | 12587465 | 4 | SS | DAIKENCHUTO | HERBALS | 1 | Oral | 7.5 G, DAILY | 0 | 7.5 | G | GRANULES | |||||||
| 125874655 | 12587465 | 5 | SS | MOSAPRIDE CITRATE HYDRATE | MOSAPRIDE CITRATE DIHYDRATE | 1 | Oral | 15 MG, DAILY | 0 | 15 | MG | ||||||||
| 125874655 | 12587465 | 6 | SS | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | 2250 MG, DAILY | 0 | 2250 | MG | ||||||||
| 125874655 | 12587465 | 7 | SS | BIO-THREE | HERBALS | 1 | Oral | UNK | 0 | ||||||||||
| 125874655 | 12587465 | 8 | SS | ISOSORBIDE DINITRATE. | ISOSORBIDE DINITRATE | 1 | Occlusive dressing technique | 40 MG, DAILY | 0 | 40 | MG | ||||||||
| 125874655 | 12587465 | 9 | SS | FAMOTIDINE OD | FAMOTIDINE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | ||||||||
| 125874655 | 12587465 | 10 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | UNK | 0 | ||||||||||
| 125874655 | 12587465 | 11 | SS | VERAPAMIL HYDROCHLORIDE. | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 120 MG, DAILY | 0 | 120 | MG | ||||||||
| 125874655 | 12587465 | 12 | SS | BAYASPIRIN | ASPIRIN | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125874655 | 12587465 | 1 | Pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125874655 | 12587465 | DE |
| 125874655 | 12587465 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125874655 | 12587465 | Hepatic function abnormal | |
| 125874655 | 12587465 | Portal vein occlusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125874655 | 12587465 | 1 | 20160705 | 20160707 | 0 | |
| 125874655 | 12587465 | 2 | 20160706 | 20160707 | 0 | |
| 125874655 | 12587465 | 3 | 20160705 | 20160707 | 0 | |
| 125874655 | 12587465 | 4 | 20160705 | 20160707 | 0 | |
| 125874655 | 12587465 | 5 | 20160705 | 20160707 | 0 | |
| 125874655 | 12587465 | 6 | 20160705 | 20160707 | 0 | |
| 125874655 | 12587465 | 7 | 20160705 | 20160707 | 0 | |
| 125874655 | 12587465 | 8 | 20160705 | 20160707 | 0 | |
| 125874655 | 12587465 | 9 | 20160705 | 20160707 | 0 | |
| 125874655 | 12587465 | 10 | 20160705 | 0 | ||
| 125874655 | 12587465 | 11 | 20160705 | 20160707 | 0 | |
| 125874655 | 12587465 | 12 | 20160705 | 20160707 | 0 |